The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Open accessAbstract
Background & aims Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the population and signifies increased risk of liver fibrosis and cirrhosis, type 2 diabetes, and cardiovascular disease. Therapies are limited. Weight loss is of benefit but is difficult to maintain. We aimed at examining the effect of the Mediterranean diet (MD), a diet high in monounsaturated fatty acids, on steatosis and insulin sensitivity, using gold standard techniques.Methods Twelve non-diabetic subjects (6 Females/6 Males) with biopsy-proven NAFLD were recruited for a randomised, cross-over 6-week dietary intervention study. All subjects undertook both the MD and a control diet, a low fat-high carbohydrate diet (LF/HCD), in random order with a 6-week wash-out period in- between. Insulin sensitivity was determined with a 3-h hyperinsulinemic-euglycemic clamp study and hepatic steatosis was assessed with localized magnetic resonance (1)H spectroscopy ((1)H-MRS).Results At baseline, subjects were abdominally obese with elevated fasting concentrations of glucose, insulin, triglycerides, ALT, and GGT. Insulin sensitivity at baseline was low (M=2.7 ± 1.0 mg/kg/min(-1)). Mean weight loss was not different between the two diets (p=0.22). There was a significant relative reduction in hepatic steatosis after the MD compared with the LF/HCD: 39 ± 4% versus 7 ± 3%, as measured by (1)H-MRS (p=0.012). Insulin sensitivity improved with the MD, whereas after the LF/HCD there was no change (p=0.03 between diets).Conclusions Even without weight loss, MD reduces liver steatosis and improves insulin sensitivity in an insulin-resistant population with NAFLD, compared to current dietary advice. This diet should be further investigated in subjects with NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In total, seven studies reported data revealed that the MD significantly reduced BMI [56–60, 62, 64](WMD = − 0.70 kg/m2, 95% CI = − 1.03 to − 0.36, P < 0.001)”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [57]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“The overall results showed that the MD significantly reduced weight [weighted mean difference (WMD = − 2.38 kg, 95% CI − 4.11 to − 0.66, P = 0.01) in comparison to standard care or control diet.”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [57]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“and WC [56–60, 62, 64] (WMD = − 1.56 cm, 95% CI = − 3.02 to − 0.09, P = 0.04) in comparison to standard care or control diet”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [57]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“while two others reported significantly lower liver fat percentages in the MD group compared to either a low-fat–high-carbohydrate diet [57] or a standard control group [64].”
The cited source says what the claim attributes to it.
In the citing paper
“the overall results of six RCTs [56, 57, 59, 60, 62, 63] showed a significant effect of the MD on ALT levels (WMD = − 3.96 IU/L, 95% CI = − 6.54 to − 1.38, P < 0.001).”
In the citing paper
“Notably, the findings demonstrated that, even in the absence of weight loss, adherence to the Mediterranean diet led to a reduction in hepatic steatosis and an improvement in insulin sensitivity (102).”
From Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility (2024) · cites this paper as [102]
In the citing paper
“Cross-sectional and longitudinal reports evidenced a lower likelihood of NASH in patients who were adherent to the MedDiet [75,76], whereas randomized controlled crossover trials defined the superiority of this diet in the improvement of insulin sensitivity, metabolic parameters and steatosis over low-fat ones [77,78].”
From Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases (2020) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Adherence to a Mediterranean diet and survival in a Greek population
Trichopoulou, A., Costacou, T., Bamia, C., & Trichopoulos, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025039 · Cited by 4,397
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,255
THE DIET AND 15-YEAR DEATH RATE IN THE SEVEN COUNTRIES STUDY
KEYS, A., MIENOTTI, A., KARVONEN, M. J., ARAVANIS, C., BLACKBURN, H., BUZINA, R., DJORDJEVIC, B. S., DONTAS, A. S., FIDANZA, F., KEYS, M. H., et al. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114480 · Cited by 1,790
Adherence to Mediterranean diet and health status: meta-analysis
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008) · BMJ · doi:10.1136/bmj.a1344 · Cited by 1,717
Sofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Elhayany, 2010, A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study, Diabetes Obes Metab, 12, 204, 10.1111/j.1463-1326.2009.01151.x · DOI · Paper page
Cited by
Sorted by citations
Items 501–600 of 777
Polycystic ovary syndrome and nonalcoholic fatty liver disease
Georgescu, C. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00007-9 · Cited by 9
Alfadda, N. A., Aljuraiban, G. S., Awwad, H. M., Khaleel, M. S., Almaghamsi, A. M., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., & Alfadda, A. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.996004 · Cited by 9
Diet and non-alcoholic fatty liver disease, a short narrative review
Kwanten, W. J. (2023) · Acta gastro-enterologica belgica · doi:10.51821/86.2.11547 · Cited by 9
Castillo, M. F., Salgado-Canales, D., Arrese, M. A., Francisco Barrera, M., & Mikhailidis, D. P. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611285401240110074530 · Cited by 7
Non-Alcoholic Fatty Liver Disease in Patients with Diabetes Mellitus: A Clinician’s Perspective
Kashanian, S. M., & Fuchs, M. A. (2015) · International Journal of Digestive Diseases · doi:10.4172/2472-1891.100010 · Cited by 8
Current treatment for non-alcoholic fatty liver disease
Moctezuma‐Velázquez, C. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.014 · Cited by 8
Fonseca, J., Nunes, G. F. D., Fonseca, C., Canhoto, M., Barata, A. T., & Santos, C. A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.036 · Cited by 8
Mandal, B., Das, R., & Mondal, S. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.02.005 · Cited by 8
Cano-Lallave, L., Ruíz-Tóvar, J., Martin-de-Bernardo, L., Martinez-Oribe, M., Rodriguez-Obispo, C., Carrascosa-Corrochano, S., Martín-Nieto, A., Baeza, I., González-Ramos, M., Benito, M., et al. (2024) · Nutrients · doi:10.3390/nu16131996 · Cited by 7
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Takawy, M., & Abdelmalek, M. F. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01579-1 · Cited by 11
Liu, D., Lv, X., Li, W., Dai, H., Tan, Y., Yang, D., & Zhang, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1621074 · Cited by 7
Rocha, L. V., Macdonald, I. A., Alssema, M., & Færch, K. (2022) · Nutrients · doi:10.3390/nu14102036 · Cited by 8
Pacheco, L. S., Bradley, R. D., Anderson, C. A. M., & Allison, M. (2022) · Nutrients · doi:10.3390/nu14132744 · Cited by 7
We are what we eat: The role of lipids in metabolic diseases
Berná, G., López-Bermudo, L., Escudero‐López, B., & Martı́n, F. (2023) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2022.11.004 · Cited by 8
Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Nendouvhada, L. P., Sibuyi, N. R. S., Fadaka, A. O., Meyer, S., Madiehe, A. M., Meyer, M., & Gabuza, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115571 · Cited by 8
Lipid profile disturbances may predispose psoriatic patients to liver dysfunction
Kozłowska, D., Harasim‐Symbor, E., Myśliwiec, H., Milewska, A. J., Chabowski, A., & Flisiak, I. (2021) · Advances in Dermatology and Allergology · doi:10.5114/ada.2021.106209 · Cited by 8
Saavedra, Y., Mena, V., & Figueroa, K. P. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.06.006 · Cited by 9
Saavedra, Y., Mena, V., & Figueroa, K. P. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.04.006 · Cited by 7
What should we advise MAFLD patients to eat and drink?
Machado, M. V. (2021) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.11 · Cited by 7
Zyoud, S. H. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00497-4 · Cited by 10
Tsukanov, V. V., Yurkina, A. S., Ushakova, T. A., & Blinov, D. V. (2016) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909.2016.9.2.017-027 · Cited by 7
THS Toxins Induce Hepatic Steatosis by Altering Oxidative Stress and SIRT1 Levels
Flores, C., Adhami, N., & Green, M. M. (2016) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000318 · Cited by 8
Arora, C., Malhotra, A., Ranjan, P., Vikram, N. K., Shalimar, S., Singh, N., & Dwivedi, S. N. (2019) · Cureus · doi:10.7759/cureus.5999 · Cited by 7
Koeckerling, D., Tomlinson, J., & Cobbold, J. (2020) · Endocrine Connections · doi:10.1530/ec-20-0174 · Cited by 7
Identifying and Treating Nonalcoholic Fatty Liver Disease.
Hunt, C. M., Turner, M. J., Gifford, E. J., Britt, R. B., & Su, G. L. (2019) · Europe PMC (PubMed Central) · Cited by 7
Ad Libitum Mediterranean or Low‐Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?
Targher, G., & Byrne, C. D. (2018) · Hepatology · doi:10.1002/hep.30142 · Cited by 7
Lai, C., Gervis, J. E., Parnell, L. D., Lichtenstein, A. H., & Ordovás, J. M. (2025) · Genes & Nutrition · doi:10.1186/s12263-025-00763-y · Cited by 6
Gut microbiota as a metabolic mediator to prevent or attenuate MASLD
Luo, J., Wei, Y., Fan, Z., Li, B., Li, L., Chai, Y., Xing, Z., Qiu, Y., Lu, W., & Fang, Z. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2545525 · Cited by 7
Scannell, N., Mantzioris, E., Cowan, S., Moran, L., & Villani, A. M. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665126104054 · Cited by 8
Zahid, M., Lal, A., Almas, A., & Parkash, O. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01353-4 · Cited by 6
Caturano, A., Nilo, D., Lorenzo, G. D., Rocco, M. P., Tagliaferri, G., Piacevole, A., Donnarumma, M., Iadicicco, I., Moretto, S. M., Acierno, C., et al. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43143 · Cited by 9
Dong, R., Zhang, R., Shen, C., Shen, Y., Shen, Z., Tian, T., & Wang, J. (2024) · Food & Function · doi:10.1039/d3fo04957d · Cited by 6
Brea, Á., Pintó, X., Ascaso, J. F., Blasco, M., Díaz, Á., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Millán, J., & Pedro‐Botet, J. (2017) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.07.001 · Cited by 6
Nutritional and Dietary Interventions for Nonalcoholic Fatty Liver Disease
Cai, C. X., Carlos, S., Solaimani, P., Trivedi, B. J., Tran, C. T., & Castelino‐Prabhu, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00029-x · Cited by 6
ANGELO, B. C., DEFENDIS, A. W., Yau, A., Alves, J. M., Thompson, P. M., Xiang, A. H., Page, K. A., & LUO, S. H. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00728-4 · Cited by 7
Zhu, X., Nima, Q., Zhang, N., Tang, D., Hu, Y., Xie, X., Zhao, X., Meng, Q., Chen, L., Jiang, X., et al. (2023) · Journal of Health Population and Nutrition · doi:10.1186/s41043-023-00485-0 · Cited by 6
Mastorakou, D., Rabaeus, M., Salen, P., Pounis, G., & de Lorgeril, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814556-2.00009-9 · Cited by 7
Rosqvist, F., Rydell, A., & Iggman, D. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.613221 · Cited by 6
Ткач, С. М., & Чеверда, Т. Л. (2016) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.1(53).2016.75839 · Cited by 6
What Is the Optimal Dietary Composition for NAFLD?
George, E. S., Tierney, A. C., Campbell, K. L., Macdonald, G. A., & Hickman, I. J. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0373-7 · Cited by 6
Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
Mayevskaya, M. V., & Ivashkin, V. T. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-5-105-116 · Cited by 7
Bueno, N. B., Silva, M. M. D. S., & de Melo, I. S. V. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.026 · Cited by 6
Mullin, S. M., Kelly, A. J., Chathail, M. B. N., Norris, S., Shannon, C. E., & Roche, H. M. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100375 · Cited by 10
Barbería-Latasa, M., Martínez‐Urbistondo, D., & Martínez‐González, M. Á. (2025) · Medicina · doi:10.3390/medicina61101777 · Cited by 5
Us, G. D., Innocenti, F., Koc, Ö. M., Alagoz, A. E., Yumuk, V., Gungor, Z. B., & Koek, G. H. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000856 · Cited by 7
Early-Life Nutritional Determinants of Pediatric MASLD
DiStefano, J. K. (2025) · Nutrients · doi:10.3390/nu17243871 · Cited by 6
Fridén, M., Rosqvist, F., Kullberg, J., Berglund, L., Vessby, J., Martinell, M., Carlsson, P., Hulthe, J., Johansson, L., Ahmad, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65613-2 · Cited by 6
Hu, Y., Lin, C., Zhang, L., Jiang, X., Li, H., & Wu, Y. (2026) · Advanced Science · doi:10.1002/advs.202523582 · Cited by 4
Lu, Q., Lu, Q., Zheng, Y.-T., Wang, Y., Liu, Y.-L., Cao, J.-Y., Liu, H., Jin, J., Zhang, Z., Yang, Y., et al. (2025) · Aquaculture Reports · doi:10.1016/j.aqrep.2025.102615 · Cited by 5
Naghizadeh, M. M., Osati, S., Homayounfar, R., & Masoudi‐Nejad, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-47752-y · Cited by 5
Moss, K., Gitman, V., Pinto-Sánchez, M. I., Oczkowski, S. J. W., Armstrong, D., Jayakumar, S., Karvellas, C. J., Selzner, N., & Dionne, J. C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079750 · Cited by 5
Dichtel, L. E., Eajazi, A., Miller, K. K., Torriani, M., & Bredella, M. A. (2016) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000423 · Cited by 5
Zelber‐Sagi, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.01.010 · Cited by 6
Diagnosis and Management of Fatty Liver
Tan, P. O., Mustaffa, N., Tan, S. S., & Lee, Y. Y. (2020) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2020.308 · Cited by 5
Dubin, S. M., Vadivelu, J., Copur‐Dahi, N., Miranda, L., Palermo, D., Pandey, B. B., Groessl, E. J., & Ho, S. B. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000523 · Cited by 4
Clinical workup of fatty liver for the primary care provider
Jensen, T., Wieland, A. C., Cree‐Green, M., Nadeau, K. J., & Sullivan, S. A. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2019.1546532 · Cited by 5
Rahideh, S. T., & Shidfar, F. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.12.09 · Cited by 5
Metabolic syndrome after liver transplantation: A silent threat to long-term success
Chan, S., Lee, J. S., Karki, P., Laryea, M. A., Huang, J. H., Lim, N., & Twohig, P. A. (2025) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v16.i4.111073 · Cited by 4
Sasada, T., Iino, C., Sato, S., Tateda, T., Igarashi, G., Yoshida, K., Sawada, K., Mikami, T., Nakaji, S., Sakuraba, H., et al. (2024) · Nutrients · doi:10.3390/nu16172877 · Cited by 4
Lago-Sampedro, A. M., Oualla‐Bachiri, W., García‐Serrano, S., Maldonado‐Araque, C., Valdés, S., Doulatram‐Gamgaram, V. K., Olveira, G., Delgado, E., Chaves, F. J., Castaño, L. A., et al. (2024) · Nutrients · doi:10.3390/nu16213788 · Cited by 4
Saslow, L. R., Krinock, J., O’Brien, A., Raymond, K., Bayandorian, H., Moskowitz, J. T., Daubenmier, J. J., Oliveri, A., Marriott, D. J., Griauzde, D. H., et al. (2025) · JMIR Formative Research · doi:10.2196/60051 · Cited by 4
Roshan, M., Mudrack, C., Sulaj, A., von Rauchhaupt, E., Fleming, T. H., Schimpfle, L., Seebauer, L., Flegka, V., Longo, V. D., Kliemank, E., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15080340 · Cited by 4
Glucose Lowering Strategies for Cardiac Benefits: Pathophysiological Mechanisms
BAJAJ, H. S., & Zinman, B. (2018) · Physiology · doi:10.1152/physiol.00004.2018 · Cited by 4
Tosi, M., Matelloni, I. A., Mancini, M., Andreassi, A., Scopari, A., Rossi, A., Verduci, E., Berra, C., Manfrini, R., Banderali, G., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02088-2 · Cited by 5
Hu, Y., Zhang, T., Song, W., Peng, Z., Zhu, Y., Huang, Y. C., Li, X., Zhang, Z., Tang, M., & Yang, W. (2023) · Public Health Nutrition · doi:10.1017/s1368980023001970 · Cited by 4
Suresh, D., Gunaseelan, B., Srinivas, A. N., Bharadwaj, A., Joseph, J., Megha, M., Varughese, T., Satish, S., Suvarna, D., Santhekadur, P. K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-96944-1 · Cited by 4
Rajan, V., Das, A., Jayaseelan, V., Lohani, K. K., & Lahariya, C. (2025) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_159_24 · Cited by 4
HIV-Associated NAFLD: Disease Burden and Management
Kaplan, A. J., & Price, J. C. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00501-0 · Cited by 4
The Mediterranean Diet in Gastrointestinal and Liver Diseases
Kataria, R. D., & Pickett‐Blakely, O. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00318-7 · Cited by 4
Xie, W., & Chen, S. (2020) · Medicine · doi:10.1097/md.0000000000023049 · Cited by 4
Dietary approaches to managing nonalcoholic fatty liver disease
Khoury, D. T. D. E., Pauley‐Hunter, R., & Berseth, C. L. (2021) · The Nurse Practitioner · doi:10.1097/01.npr.0000731560.23509.ff · Cited by 4
Functional Foods for the Management of Non-Alcoholic Fatty Liver Disease
Palanisamy, V. V., Vijayan, N., Vijay, V., Vallikannan, B., & Perumal, M. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96317 · Cited by 4
Mosavat, S. H., Razmgah, G. R. G., Hosseini, S. M., Nematy, M., Esmaily, H., Yousefi, M., & Kamalinejad, M. (2017) · Galen Medical Journal · doi:10.31661/gmj.v6i3.813 · Cited by 4
Understanding and Diagnosing Hyperinsulinaemia
Crofts, C. A. P. (2015) · Tuwhera (Auckland University of Technology) · Cited by 4
Zou, J., Tian, F., Cui, S., Hou, J. Y., Li, Z., Wei, Y., Cui, H., Li, Y., Zhou, S., He, Z., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04535-1 · Cited by 4
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight
Cossiga, V., Cazzagon, N., Montalti, R., Ciminnisi, S., Attanasio, M. R., Pezzato, F., Giacchetto, M., Guarino, M., Calvaruso, V., Floreani, A., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.12.009 · Cited by 3
Liver phospholipid fatty acid composition in response to chronic high-fat diets
Popović, T. B., Nenadović, A., Stanković, A., Debeljak-Martačić, J., Ranković, S., Kovačević, S., Ostojić, J. N., Ilić, A. Ž., Milašin, J., Luka, S. R. D., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159526 · Cited by 4
Kitsios, K., Trakatelli, C., Antza, C., Triantafyllou, Α., Sarigianni, M., & Kotsis, V. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0059 · Cited by 3
The main approaches to dietary changes in non-alcoholic fatty liver disease
Drapkina, O. M., Шепель, Р. Н., Starodubova, A. V., & Evsutina, Y. V. (2018) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20182106178 · Cited by 3
Karahan, T. Ö., Yilmaz, Y. N., & Güneş, F. E. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02809-9 · Cited by 3
Scientific Division, R., & Spandana, M. S. . (2022) · International Journal of Preclinical and Clinical Research · doi:10.51131/ijpccr/v3i1.22_17 · Cited by 3
Martín, I. S. M., Vilar, E. G., Rojo, S. S., Oliva, S. L., Martínez, S., & Lora, A. T. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04635 · Cited by 3
Сергеевна, К. Т., Syrovenko, M. I., & Livzan, M. A. (2023) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro20231204143 · Cited by 3
The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease
Ahmed, A., Maham, K., Afzaal, M., Saleem, M. A., Nadeem, M., Saeed, F., Hussain, M., & Jbawi, E. M. A. (2024) · Cogent Food & Agriculture · doi:10.1080/23311932.2024.2325206 · Cited by 4
Shakhshir, M. H., & Zyoud, S. H. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i24.3106 · Cited by 3
Ruíz-Tóvar, J., Llavero, C., Ortega, M. R., Castro, N. M. D., Martín-Crespo, M. C., Escobar‐Aguilar, G., Martín-Nieto, A., & González, G., V (2024) · Nutrients · doi:10.3390/nu16142280 · Cited by 3
Nicastro, E., & D’Antiga, L. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58572-2_7 · Cited by 3
The pharmacological treatment of nonalcoholic fatty liver disease in children
Crudele, A., Panera, N., Braghini, M. R., Balsano, C., & Alisi, A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1829468 · Cited by 3
Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
Basu, A., Basu, P., & Lyons, T. J. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_35 · Cited by 3
Oh, H., Ahn, J., & Jun, D. W. (2017) · Korean Journal of Medicine · doi:10.3904/kjm.2017.92.2.112 · Cited by 3
Sanchez-Torrijos, Y. M., Álvarez‐Amor, L., Aller, R., García‐Luna, P. P., Martín, F., & Romero‐Gómez, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_15 · Cited by 4
Nilsen, I., Andersson, A., Laurenius, A., Österberg, J., Sundbom, M., & Haenni, A. (2021) · Nutrients · doi:10.3390/nu13113687 · Cited by 4
Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease
Al-Samhari, G. A., Al-Mushiki, G. M., Tamrakar, R., ABDULLAHI, G., Lin, Y.-D., & Tang, X. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.366 · Cited by 4
Anwar, M. (2014) · World Journal of Pharmacology · doi:10.5497/wjp.v3.i4.209 · Cited by 3
Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver
Stokes, C. S., Lammert, F., & Krawczyk, M. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170508144409 · Cited by 3
Ryan, M. C., Desmond, P. V., & Wilson, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.022 · Cited by 3
Self-citationHuang, L., Qu, S., Cui, X., Jin, Y., & Yao, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-05044-7 · Cited by 2
Sood, S., Roberts, S. K., Scott, D. S., Keating, S. E., Tan, S., George, J., Kiss, N. K., Daly, R. M., Dunstan, D. W., Tucker, R. M., et al. (2025) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x251366098 · Cited by 2
Metadata
- Authors
- Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M.
- Affiliations
- St Vincent's Hospital Melbourne (AU)
- La Trobe University (AU)
- University of South Australia (AU)
- The University of Sydney (AU)
- Corresponding author
- Ryan, Marno C.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 59
- Issue
- 1
- Pages
- 138-143
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2053985254
- Cited by
- 778
- References
- 46
- Citations by year
- 2026: 39 · 2025: 59 · 2024: 66 · 2023: 90 · 2022: 66 · 2021: 71 · 2020: 77 · 2019: 70 · 2018: 69 · 2017: 52 · 2016: 50 · 2015: 26 · 2014: 29 · 2013: 12
- FWCI
- 28.42
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- Mediterranean diet, non-alcoholic fatty liver disease, hepatic steatosis, insulin sensitivity, monounsaturated fatty acids, low-fat high-carbohydrate diet, dietary intervention, hyperinsulinemic-euglycemic clamp, 1H magnetic resonance spectroscopy, weight loss, insulin resistance
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Humans, Insulin Resistance, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Glucose Clamp Technique, Cross-Over Studies, Diet, Mediterranean, Lipid Metabolism, Obesity, Abdominal, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review